Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

The new fluoroquinolone effectively fights certain bacteria.

The patches could quickly deliver epilepsy treatment and reduce seizures.

Bhangra may help treat premature greying of hair by boosting melanin and improving scalp health.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Minoxidil and finasteride for hair loss may cause different types of heart rhythm issues.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

CaBP1 and 2 are necessary for maintaining calcium currents and hearing in inner ear cells.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Baricitinib can cause excessive hair growth.

Rebamipide may help regrow hair by activating hair follicle stem cells.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.